nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—PDE6G—optic choroid—ocular cancer	0.192	0.272	CbGeAlD
Sildenafil—PDE6H—pineal body—ocular cancer	0.132	0.188	CbGeAlD
Sildenafil—PDE6G—Activation of the phototransduction cascade—SAG—ocular cancer	0.0732	0.248	CbGpPWpGaD
Sildenafil—PDE6C—eye—ocular cancer	0.0681	0.0966	CbGeAlD
Sildenafil—PDE6C—retina—ocular cancer	0.0675	0.0957	CbGeAlD
Sildenafil—PDE6H—eye—ocular cancer	0.0401	0.0569	CbGeAlD
Sildenafil—PDE6H—retina—ocular cancer	0.0398	0.0564	CbGeAlD
Sildenafil—PDE6G—Visual signal transduction: Rods—SAG—ocular cancer	0.0392	0.133	CbGpPWpGaD
Sildenafil—PDE6G—eye—ocular cancer	0.0386	0.0548	CbGeAlD
Sildenafil—PDE6G—retina—ocular cancer	0.0383	0.0543	CbGeAlD
Sildenafil—PDE6G—Inactivation, recovery and regulation of the phototransduction cascade—SAG—ocular cancer	0.0312	0.106	CbGpPWpGaD
Sildenafil—PDE6G—The phototransduction cascade—SAG—ocular cancer	0.0304	0.103	CbGpPWpGaD
Sildenafil—PDE5A—eye—ocular cancer	0.0153	0.0217	CbGeAlD
Sildenafil—PDE5A—retina—ocular cancer	0.0151	0.0215	CbGeAlD
Sildenafil—PDE5A—epithelium—ocular cancer	0.014	0.0198	CbGeAlD
Sildenafil—ABCC5—retina—ocular cancer	0.0138	0.0196	CbGeAlD
Sildenafil—PDE6G—Diseases associated with visual transduction—SAG—ocular cancer	0.013	0.0442	CbGpPWpGaD
Sildenafil—ADORA2A—lymphoid tissue—ocular cancer	0.0118	0.0168	CbGeAlD
Sildenafil—ADORA2A—Monoamine Transport—RBL2—ocular cancer	0.0104	0.0352	CbGpPWpGaD
Sildenafil—ABCC10—lymphoid tissue—ocular cancer	0.00822	0.0117	CbGeAlD
Sildenafil—CYP1A1—epithelium—ocular cancer	0.00593	0.00842	CbGeAlD
Sildenafil—CYP2E1—lymphoid tissue—ocular cancer	0.00417	0.00591	CbGeAlD
Sildenafil—ADORA2A—Circadian rythm related genes—CRTC1—ocular cancer	0.00325	0.011	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—ID2—ocular cancer	0.0029	0.00982	CbGpPWpGaD
Sildenafil—ADORA2A—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.00201	0.00681	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—HDAC1—ocular cancer	0.00198	0.00671	CbGpPWpGaD
Sildenafil—ABCC5—Fluoropyrimidine Activity—TP53—ocular cancer	0.00186	0.00632	CbGpPWpGaD
Sildenafil—PDE6G—Disease—SAG—ocular cancer	0.00166	0.00561	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—GNA11—ocular cancer	0.00158	0.00537	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—GNAQ—ocular cancer	0.00147	0.00499	CbGpPWpGaD
Sildenafil—PDE6G—Disease—E2F5—ocular cancer	0.00147	0.00497	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—GNA11—ocular cancer	0.00145	0.00492	CbGpPWpGaD
Sildenafil—PDE6G—Disease—E2F4—ocular cancer	0.00144	0.00487	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00142	0.0048	CbGpPWpGaD
Sildenafil—PDE6G—Disease—RPL39—ocular cancer	0.00141	0.00477	CbGpPWpGaD
Sildenafil—PDE6G—Disease—RBL1—ocular cancer	0.00141	0.00477	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—GNAQ—ocular cancer	0.00135	0.00457	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—HDAC1—ocular cancer	0.00133	0.0045	CbGpPWpGaD
Sildenafil—ABCC4—Fluoropyrimidine Activity—TP53—ocular cancer	0.00129	0.00438	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00122	0.00414	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—HDAC1—ocular cancer	0.00122	0.00412	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00118	0.004	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SAG—ocular cancer	0.00116	0.00393	CbGpPWpGaD
Sildenafil—PDE6G—Disease—TFDP1—ocular cancer	0.00114	0.00385	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PSPH—ocular cancer	0.00113	0.00383	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.0011	0.00372	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—E2F5—ocular cancer	0.00103	0.00348	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—E2F4—ocular cancer	0.00101	0.00341	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00101	0.00341	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—RBL1—ocular cancer	0.000986	0.00334	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—CDK2—ocular cancer	0.000942	0.00319	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—HDAC1—ocular cancer	0.000918	0.00311	CbGpPWpGaD
Sildenafil—CYP2E1—Tryptophan metabolism—MDM2—ocular cancer	0.000909	0.00308	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MAML2—ocular cancer	0.000902	0.00306	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SAG—ocular cancer	0.000895	0.00303	CbGpPWpGaD
Sildenafil—CYP1A1—Tryptophan metabolism—MDM2—ocular cancer	0.000857	0.0029	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—E2F3—ocular cancer	0.000855	0.0029	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—CDK4—ocular cancer	0.000816	0.00277	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TFDP1—ocular cancer	0.000795	0.00269	CbGpPWpGaD
Sildenafil—ABCC5—Disease—E2F5—ocular cancer	0.000792	0.00268	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—EP300—ocular cancer	0.00079	0.00267	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.000783	0.00265	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.000783	0.00265	CbGpPWpGaD
Sildenafil—ABCC5—Disease—E2F4—ocular cancer	0.000776	0.00263	CbGpPWpGaD
Sildenafil—ABCC4—Platelet degranulation—TGFB1—ocular cancer	0.000773	0.00262	CbGpPWpGaD
Sildenafil—ABCC5—Disease—RBL1—ocular cancer	0.000761	0.00258	CbGpPWpGaD
Sildenafil—ABCC5—Disease—RPL39—ocular cancer	0.000761	0.00258	CbGpPWpGaD
Sildenafil—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000736	0.00249	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.000722	0.00245	CbGpPWpGaD
Sildenafil—ABCC5—NRF2 pathway—TGFB1—ocular cancer	0.000689	0.00233	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—MYC—ocular cancer	0.000688	0.00233	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000687	0.00233	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.000687	0.00233	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HDAC1—ocular cancer	0.00066	0.00223	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAML2—ocular cancer	0.000632	0.00214	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TFDP1—ocular cancer	0.000613	0.00208	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—GNA11—ocular cancer	0.000608	0.00206	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000599	0.00203	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000597	0.00202	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.000593	0.00201	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CDKN2B—ocular cancer	0.000591	0.002	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PSPH—ocular cancer	0.00057	0.00193	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—GNAQ—ocular cancer	0.000566	0.00192	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GNA11—ocular cancer	0.000551	0.00187	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000542	0.00184	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—EP300—ocular cancer	0.000529	0.00179	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GNAQ—ocular cancer	0.000512	0.00174	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HDAC1—ocular cancer	0.00051	0.00173	CbGpPWpGaD
Sildenafil—ABCC4—Ectoderm Differentiation—MYC—ocular cancer	0.000501	0.0017	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.0005	0.00169	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SAG—ocular cancer	0.000495	0.00168	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAML2—ocular cancer	0.000487	0.00165	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—EP300—ocular cancer	0.000485	0.00164	CbGpPWpGaD
Sildenafil—ABCC4—NRF2 pathway—TGFB1—ocular cancer	0.000478	0.00162	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—AKT1—ocular cancer	0.000477	0.00162	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00047	0.00159	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HDAC1—ocular cancer	0.000462	0.00156	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TGFB1—ocular cancer	0.00046	0.00156	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—MDM2—ocular cancer	0.000456	0.00155	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—GNA11—ocular cancer	0.000439	0.00149	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—E2F5—ocular cancer	0.000438	0.00148	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—E2F4—ocular cancer	0.000429	0.00145	CbGpPWpGaD
Sildenafil—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000422	0.00143	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RBL1—ocular cancer	0.000421	0.00143	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—CDKN1B—ocular cancer	0.000417	0.00141	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CDKN2B—ocular cancer	0.000414	0.0014	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PSPH—ocular cancer	0.000413	0.0014	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PSPH—ocular cancer	0.000412	0.0014	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—GNAQ—ocular cancer	0.000408	0.00138	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—GNA11—ocular cancer	0.000398	0.00135	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PSPH—ocular cancer	0.000389	0.00132	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—CDKN1A—ocular cancer	0.000385	0.0013	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—E2F1—ocular cancer	0.00038	0.00129	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TP53—ocular cancer	0.000379	0.00128	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—GNAQ—ocular cancer	0.00037	0.00125	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—E2F3—ocular cancer	0.000365	0.00124	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—HRAS—ocular cancer	0.000362	0.00123	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—CDK2—ocular cancer	0.000362	0.00123	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HDAC1—ocular cancer	0.000356	0.00121	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GNA11—ocular cancer	0.000356	0.00121	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TP53—ocular cancer	0.000347	0.00118	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000343	0.00116	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	0.000342	0.00116	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TFDP1—ocular cancer	0.000339	0.00115	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.000335	0.00113	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GNAQ—ocular cancer	0.000331	0.00112	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MDM2—ocular cancer	0.000328	0.00111	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000326	0.0011	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—AKT1—ocular cancer	0.00032	0.00108	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN2B—ocular cancer	0.000319	0.00108	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PSPH—ocular cancer	0.000318	0.00108	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CDKN1B—ocular cancer	0.000299	0.00101	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PSPH—ocular cancer	0.000293	0.000992	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PSPH—ocular cancer	0.00029	0.000984	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000288	0.000974	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CDKN1A—ocular cancer	0.000276	0.000936	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAML2—ocular cancer	0.00027	0.000913	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EP300—ocular cancer	0.000263	0.000891	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—HRAS—ocular cancer	0.00025	0.000848	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000238	0.000807	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GNA11—ocular cancer	0.000235	0.000797	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000231	0.000782	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MDM2—ocular cancer	0.00023	0.000778	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MYC—ocular cancer	0.000229	0.000776	CbGpPWpGaD
Sildenafil—PDE6G—Disease—TGFB1—ocular cancer	0.000229	0.000774	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—AKT1—ocular cancer	0.000221	0.000749	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GNAQ—ocular cancer	0.000219	0.000741	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CDKN1B—ocular cancer	0.00021	0.00071	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—EP300—ocular cancer	0.000203	0.000689	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CCND1—ocular cancer	0.0002	0.000678	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HDAC1—ocular cancer	0.000197	0.000668	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CDKN1A—ocular cancer	0.000194	0.000656	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PSPH—ocular cancer	0.000191	0.000649	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EP300—ocular cancer	0.000184	0.000624	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HRAS—ocular cancer	0.00018	0.00061	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GNA11—ocular cancer	0.000179	0.000607	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MDM2—ocular cancer	0.000177	0.0006	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN2B—ocular cancer	0.000177	0.000599	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TGFB1—ocular cancer	0.000177	0.000599	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GNAQ—ocular cancer	0.000167	0.000565	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—E2F1—ocular cancer	0.000162	0.000549	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN1B—ocular cancer	0.000162	0.000548	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—ocular cancer	0.00016	0.000544	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TGFB1—ocular cancer	0.00016	0.000542	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—ocular cancer	0.000159	0.000538	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN1A—ocular cancer	0.000149	0.000506	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—ocular cancer	0.000145	0.000493	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EP300—ocular cancer	0.000142	0.000481	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HRAS—ocular cancer	0.000139	0.000471	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—ocular cancer	0.000132	0.000446	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GNA11—ocular cancer	0.00013	0.00044	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GNA11—ocular cancer	0.00013	0.000439	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—ocular cancer	0.000126	0.000427	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—ocular cancer	0.000124	0.000419	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TGFB1—ocular cancer	0.000123	0.000418	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—ocular cancer	0.000123	0.000416	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GNA11—ocular cancer	0.000122	0.000415	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GNAQ—ocular cancer	0.000121	0.000409	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GNAQ—ocular cancer	0.000121	0.000408	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—EP300—ocular cancer	0.000119	0.000403	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GNAQ—ocular cancer	0.000114	0.000386	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—ocular cancer	0.000111	0.000377	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GNA11—ocular cancer	0.0001	0.000339	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MDM2—ocular cancer	9.8e-05	0.000332	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—ocular cancer	9.72e-05	0.000329	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GNAQ—ocular cancer	9.32e-05	0.000316	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GNA11—ocular cancer	9.22e-05	0.000312	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.19e-05	0.000311	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GNA11—ocular cancer	9.14e-05	0.00031	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—ocular cancer	9.11e-05	0.000308	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1B—ocular cancer	8.95e-05	0.000303	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—ocular cancer	8.85e-05	0.0003	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—ocular cancer	8.58e-05	0.000291	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GNAQ—ocular cancer	8.57e-05	0.00029	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—ocular cancer	8.54e-05	0.000289	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GNAQ—ocular cancer	8.49e-05	0.000288	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1A—ocular cancer	8.26e-05	0.00028	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—ocular cancer	8.04e-05	0.000272	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EP300—ocular cancer	7.86e-05	0.000266	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.52e-05	0.000255	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—ocular cancer	7.19e-05	0.000243	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.85e-05	0.000232	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—ocular cancer	6.85e-05	0.000232	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFB1—ocular cancer	6.83e-05	0.000231	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GNA11—ocular cancer	6.03e-05	0.000204	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—EP300—ocular cancer	5.99e-05	0.000203	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—ocular cancer	5.62e-05	0.000191	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GNAQ—ocular cancer	5.6e-05	0.00019	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—ocular cancer	5.38e-05	0.000182	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—ocular cancer	4.75e-05	0.000161	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—EP300—ocular cancer	4.34e-05	0.000147	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—EP300—ocular cancer	4.33e-05	0.000147	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—EP300—ocular cancer	4.09e-05	0.000139	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—ocular cancer	3.62e-05	0.000123	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—EP300—ocular cancer	3.35e-05	0.000113	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—EP300—ocular cancer	3.08e-05	0.000104	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—EP300—ocular cancer	3.05e-05	0.000103	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—ocular cancer	2.62e-05	8.88e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—ocular cancer	2.62e-05	8.87e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—ocular cancer	2.47e-05	8.38e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—ocular cancer	2.02e-05	6.85e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—EP300—ocular cancer	2.01e-05	6.82e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—ocular cancer	1.86e-05	6.3e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—ocular cancer	1.84e-05	6.25e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—ocular cancer	1.22e-05	4.12e-05	CbGpPWpGaD
